Register entry

VERO BIOTECH INC.

Registered sites
2
Drug products
4
Live patents
13
Countries
1
Base
United States
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Analytical testingFinished drug manufacture
Sites

Facilities

2
SiteLocationOperationsFEI
VERO BIOTECH INC.Atlanta, GAUnited StatesAnalytical testing, Finished drug manufacture3014617112
VERO BIOTECH INC.Austell, GAUnited StatesFinished drug manufacture3027057342
Exclusivity

Patents

13

Unexpired Orange Book patents where this company is the application holder.

ProductActive ingredientExpiry
GENOSYLNITRIC OXIDEOct 2026
GENOSYLNITRIC OXIDEApr 2027
GENOSYLNITRIC OXIDEJan 2029
GENOSYLNITRIC OXIDEAug 2029
GENOSYLNITRIC OXIDESept 2029
GENOSYLNITRIC OXIDEJun 2030
GENOSYLNITRIC OXIDEJul 2030
GENOSYLNITRIC OXIDEOct 2035
GENOSYLNITRIC OXIDEFeb 2036
GENOSYLNITRIC OXIDEJul 2040
Catalogue

Marketed products

4

Showing 4 of 4.

BrandGeneric nameFormCategory
GENOSYLnitric oxideGASNDA
GENOSYLnitric oxideGASNDA
GENOSYLnitric oxideGASNDA
Noxiventnitric oxideGASANDA
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.